These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Armed human monocytes challenged with a sensitizing cancer extract release substances pharmacologically similar to leukotrienes. Thomson DM; Phelan K; Morton DG; Bach MK Int J Cancer; 1982 Sep; 30(3):299-306. PubMed ID: 7129679 [TBL] [Abstract][Full Text] [Related]
5. Ketotifen, disodium cromoglycate, and verapamil inhibit leukotriene activity: determination by tube leukocyte adherence inhibition assay. Fink A; Bibi H; Eliraz A; Schlesinger M; Bentwich Z Ann Allergy; 1986 Aug; 57(2):103-6. PubMed ID: 3090908 [TBL] [Abstract][Full Text] [Related]
6. Modulation of antigen-induced leukocyte adherence inhibition by metabolites of arachidonic acid and intracellular nucleotides. Thomson DM; Phelan K; Scanzano R; Fink A Int J Cancer; 1982 Sep; 30(3):311-9. PubMed ID: 6752047 [TBL] [Abstract][Full Text] [Related]
7. Role of cyclooxygenase products in the lung action of leukotrienes A4, B4, C4, D4 and E4. Sirois P; Chagnon M; Borgeat P; Vallerand P Pharmacology; 1985; 31(4):225-36. PubMed ID: 2997811 [TBL] [Abstract][Full Text] [Related]
12. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification]. Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577 [TBL] [Abstract][Full Text] [Related]
13. Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Levine JD; Lau W; Kwiat G; Goetzl EJ Science; 1984 Aug; 225(4663):743-5. PubMed ID: 6087456 [TBL] [Abstract][Full Text] [Related]
14. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays. Shenouda G; Thomson DM; MacFarlane JK Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056 [TBL] [Abstract][Full Text] [Related]
15. Leukotriene F4 and the release of arachidonic acid metabolites from perfused guinea pig lungs in vitro. Lord A; Charleson S; Letts LG Prostaglandins; 1985 Apr; 29(4):651-60. PubMed ID: 3923570 [TBL] [Abstract][Full Text] [Related]
16. Oxidative metabolism, cytoskeletal system, and calcium entry of leukocytes in the phenomenon of sensitizing cancer extract-induced leukocyte adherence inhibition. Thomson DM; Phelan K; Scanzano R Cancer Res; 1983 Mar; 43(3):1066-73. PubMed ID: 6681728 [TBL] [Abstract][Full Text] [Related]
17. Effect of calcium ionophore A23187 and of leukotrienes B4 and C4 on the adherence of human mononuclear leukocytes. Mayer M Biomed Biochim Acta; 1988; 47(1):83-7. PubMed ID: 2839164 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase inhibitors promote the leukotriene C4 induced release of beta-glucuronidase from rat peritoneal macrophages: prostaglandin E2 suppresses. Schenkelaars EJ; Bonta IL Int J Immunopharmacol; 1986; 8(3):305-11. PubMed ID: 3089952 [TBL] [Abstract][Full Text] [Related]
19. Leukotriene C4 and D4 contract rat glomerular mesangial cells. Simonson MS; Dunn MJ Kidney Int; 1986 Oct; 30(4):524-31. PubMed ID: 3465969 [TBL] [Abstract][Full Text] [Related]
20. Leukocyte activation in advanced cancer as an explanation for absent leukocyte adherence inhibition to cancer extracts and chemoattractant. Labateya N; Thomson DM; Reid EC Eur J Cancer Clin Oncol; 1986 Jan; 22(1):33-43. PubMed ID: 3007156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]